buyWeak
Goldentree Asset Management LP bought $4.3M of Keenova Therapeutics plc
owner at Keenova Therapeutics plc. 50,000 shares at an average of $86.50, traded Aug 1, 2025, filed Aug 4, 2025.
Conviction score
27Value
$4.3M
50,000 shares
Holdings after
7,909,476
+1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +25Trade size$4.3M at market
- -5Relative to holdingsUnder 1% of holdings (0.6%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001641172-25-022063, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 31, 2025 | JOther Ordinary Sharesindirect: See footnotes | +4,539,148 | - | - | 7,859,476 | Aug 4, 2025 |
| Aug 1, 2025 | POpen-market purchase Ordinary Sharesindirect: See footnotes | +50,000 | $86.50 | $4.3M | 7,909,476 | Aug 4, 2025 |
Related signals
Other insiders at Keenova Therapeutics plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | -buy Keenova Therapeutics plc | Goldentree Asset Management LP owner | $42M 463,000 shares | +6% | |
| 37Weak | -buy Keenova Therapeutics plc | Silver Point Capital L.P. owner | $12M 130,974 shares | +3% | |
| 37Weak | -buy Keenova Therapeutics plc | Silver Point Capital L.P. owner | $6.0M 68,000 shares | +2% | |
| 35Weak | -buy Keenova Therapeutics plc | Silver Point Capital L.P. owner | $27M 290,000 shares | +7% | |
| 32Weak | -buy Keenova Therapeutics plc | Goldentree Asset Management LP owner | $3.2M 36,700 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.